Top Influencers: 10 UK Founder and Chief Scientific Officer’s To Follow in 2022

2 years ago

Co Founder and Chief Scientific Officer play a crucial role in any startup. It takes an extraordinary person to fulfil the Co Founder and Chief Scientific Officer role. We have selected these Co Founder and Chief Scientific Officer’s for this list as they are inspiring for a variety of reasons – whether that’s pushing boundaries, creating groundbreaking products, or doing their bit to save the world.

Our analysts did their best to select be best, and most innovative Co Founder and Chief Scientific Officer’s. The list is in no particular order!

Charles Nduka

Co Founder and Chief Scientific Officer @ Emteq

FollowCharles Nduka on Facebook, Twitter or Linkedin.

Spoiler title
Charles Nduka studied medicine at Oxford University, where he also undertook an undergraduate intercalated degree on Physiological Sciences. He completed his clinical studies for the MB BS degree at St. Mary’s Hospital, in London. He graduated as a doctor in 1994 with a Distinction in Surgery. He was also awarded Honours in Surgery by the University of London. Following his internship he spent 2 years in full-time research with Professor Sir Ara Darzi at Imperial College in the Department of Biosurgery and Surgical Technology. For his thesis on he was awarded a doctoral degree (MD, Doctor of Medicine) by the University of London. He undertook his surgical training in London teaching Hospitals including the Royal London & St Bartholomew’s Hospital, Charing Cross and Hammersmith Hospitals. He completed his specialist training at the Royal Marsden Hospital. He was awarded the Macgregor Gold Medal for his performance in the plastic and reconstructive surgery FRCS examination. Charles has a long track record of R &D and has worked with industrial partners on clinical trials, technology evaluations or as a consultant for 20 years. Previous collaborators include Glaxo-Smithkline, 3DmD, Allergan, ICN, Johnson and Johnson. He has won numerous research awards including from the Wellcome Trust, the National Institute for Health Research, Innovate UK and the Nominet Trust. He is an internationally recognised specialist in facial muscle disorders and in 2007 established the largest unit treating facial paralysis in the UK at the Queen Victoria Hospital. He has multiple patents pending. In 2013 he identified the potential of wearable sensors for monitoring facial muscle activity and funded the development of prototype sensors and proof of concept technologies. He has taken a sabbatical from his full-time clinical role at Queen Victoria Hospital in order to focus on Emteq and develop further IP and products. Learn more about Charles Nduka on Crunchbase…

The world’s first emotion recognition and analysis platform in smart glasses Read more aboutEmteq on Crunchbase…

Tuomas Knowles

Founder and Chief Scientific Officer @ Fluidic Analytics

FollowTuomas Knowles on Facebook, Twitter or Linkedin.

Spoiler title
Professor Tuomas Knowles holds a personal Professorship in the Department of Chemistry at the University of Cambridge and is also a Fellow of St John’s College Cambridge. Tuomas received his PhD in Physics from the University of Cambridge, and has held positions in Engineering in Cambridge and Harvard University before returning to Cambridge as a University Lecturer in 2010, Reader in 2013 and then Professor in 2015. His current research interests are focused on using physical approaches to study the self-assembly of protein molecules both in the context of disease and for the synthesis of novel functional biomaterials. Tuomas has received a number of distinguished awards, most recently from the Royal Society of Chemistry, the Newman Foundation and the European Research Council, and has co-authored over 60 peer-reviewed scientific articles. Learn more about Tuomas Knowles on Crunchbase…

Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised. Read more aboutFluidic Analytics on Crunchbase…

Clement Champion

Co-Founder and Chief Scientific Officer @ MoA Technology Ltd

FollowClement Champion on Facebook, Twitter or Linkedin.

Spoiler title
Clément graduated from the French Grandes Écoles with an Engineer’s degree in Agronomy before moving to Oxford in 2012. He was awarded a Clarendon scholarship to work on the genetic control of plant growth in Prof. Dolan’s research group. After completing his D. Phil, Clément contributed to the conception of MoA Technology’s discovery platforms and has since been leading the biology research group. Learn more about Clement Champion on Crunchbase…

MoA Technology Ltd has developed an innovative approach for the discovery of agricultural technologies. Read more aboutMoA Technology Ltd on Crunchbase…

David O’Rourke

Co-Founder and Chief Scientific Officer (CSO) & Chief Innovation Officer (CIO) @ Bea Fertility

FollowDavid O’Rourke on Facebook, Twitter or Linkedin.

Spoiler title
David O’Rourke is the Chief Operating Officer and Co-Founder of Bea Fertility. Learn more about David O’Rourke on Crunchbase…

Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking. Read more aboutBea Fertility on Crunchbase…

Nirmesh Patel

Co-Founder and Chief Scientific Officer @ Cambridge Cancer Genomics

FollowNirmesh Patel on Facebook, Twitter or Linkedin.

Spoiler title
Nirmesh spearheads the clinical research and establishes experimental developments at CCG, sitting at the interface between clinical collaborators and the lab. He brings a deep understanding of the clinical applications of cancer biology, with a background in translational cancer medicine and novel therapeutic development through his PhD at King’s College London and the Institute of Cancer Research. Learn more about Nirmesh Patel on Crunchbase…

Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Read more aboutCambridge Cancer Genomics on Crunchbase…

Trevor Lawley

Co-Founder and Chief Scientific Officer @ Microbiotica

FollowTrevor Lawley on Facebook, Twitter or Linkedin.

[custom-twitter-feeds screenname=”lawleylab”]
Spoiler title
Trevor Lawley is a co-founder and Chief Scientific Officer of Microbiotica. He is also Faculty Group Leader of the Host-Microbiota Interactions Team at the Wellcome Trust Sanger Institute (WTSI), where his research uses advanced metagenomic sequencing and deep culturing to investigate the microbial communities contained on and within host organisms that are associated with health and a range of diseases and syndromes such as infections, autoimmunity, irritable bowel syndromes and cancer. He has pioneered many aspects of the bacteriotherapy concept where defined mixtures of bacteria are used to cure intestinal diseases linked to pathological imbalances in the intestinal microbiota. Trevor began his research at WTSI in 2007 as a Post-Doctoral Fellow in the Microbial Pathogenesis group, having received a Royal Society Fellowship to start a new research programme in C. difficile epidemiology and pathogenesis. During this time, he has worked with a global consortium from over 25 institutes to assemble a comprehensive C. difficile culture collection, now housed within the Sanger Institute. Prior to joining WTSI, Trevor held a Canadian Institutes of Health Research post-doctoral fellowship, working in the Laboratory of Professor Stanley Falkow and Dr Denise Monack at Stanford University, USA, where he studied the impact of antibiotic treatment on Salmonella disease and transmission. Trevor gained his first degree from Acadia University, Canada and his PhD from the University of Alberta, Canada, where he pioneered the use of genomics to study the origins and spread of antibiotic resistance in infectious diseases. He received the Canadian Society of Microbiologists Graduate Student of the Year Award for this work. More recently, Trevor was recognised by the Peggy Lillis Foundation with their Innovator Award 2015 for his ground-breaking work on developing bacteriotherapy for C. difficile infections. Learn more about Trevor Lawley on Crunchbase…

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. Read more aboutMicrobiotica on Crunchbase…

Iva Navratilova

Founder and Chief Scientific Officer @ Kinetic Discovery Ltd.

FollowIva Navratilova on Facebook, Twitter or Linkedin.

Spoiler title
Dr Iva Navratilova has over 17 years experience in biosensor technology development and is the pioneer of the application of SPR screening methods for membrane proteins. Learn more about Iva Navratilova on Crunchbase…

Kinetic Discovery Ltd offers drug discovery services as hit identification, confirmation and validation. Read more aboutKinetic Discovery Ltd. on Crunchbase…

Dapeng Yu

Founder and Chief Scientific Officer @ Previsico

FollowDapeng Yu on Facebook, Twitter or Linkedin.

Spoiler title
Dapeng Yu is a Professor of River Dynamics at Loughborough University. He is the founder and Chief Scientific Officer of Previsico. Learn more about Dapeng Yu on Crunchbase…

Previsico is a global provider of real-time, street level flood prediction, and analytical solutions, building round-the-clock resilience. Read more aboutPrevisico on Crunchbase…

Stuart Cockerill

Founder and Chief Scientific Officer @ ReViral

FollowStuart Cockerill on Facebook, Twitter or Linkedin.

[custom-twitter-feeds screenname=”gscockerill”]
Spoiler title
Stuart Cockerill PhD Chief Scientific Officer, Founder Stuart was the Principal Investigator on a Wellcome Trust funded Project, on behalf of ReViral. He obtained his PhD in Organic Chemistry at the University of Leeds. After a Postdoctoral fellowship at Cornell University, he joined the GSK heritage company, the Wellcome Foundation and over the next 15 years led drug discovery projects in Pesticides, Immunology, Virology and Oncology. His key achievement was leading the erbB2 Oncology Project Team that discovered Tykerb™ for which Stuart is a named inventor. In December 2000, Stuart joined Arrow Therapeutics as Head of Chemistry and subsequently as Research Director. Stuart remained as Head of Arrow until the end of 2010. Stuart held the position of Senior Lecturer in Medicinal Chemistry at the University of Durham. His key achievements were two clinical Proof of Concept drug candidates involving novel approaches to the treatment of Respiratory Syncytial Virus and Hepatitis C Virus infection. Stuart is an author of over 70 papers, patents and book chapters. Learn more about Stuart Cockerill on Crunchbase…

ReViral is a biotechnology company that develops and offers antiviral therapies for patients. Read more aboutReViral on Crunchbase…

Charalambos Antoniades

Founder and Chief Scientific Officer @ Caristo Diagnostics

FollowCharalambos Antoniades on Facebook, Twitter or Linkedin.

Caristo Diagnostics utilises standard CT scans to identify potentially heart-stopping plaques Read more aboutCaristo Diagnostics on Crunchbase…

David Friedland

Bit of a gear addict.

Leave a Reply

Your email address will not be published.